ArticleHuman vaccines & immunotherapeutics2026

Cost-effectiveness analysis of 23-valent pneumococcal polysaccharide vaccine for elderly in Zhejiang province, China.

Zilian Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.